88 Energy launches share placing to fund upcoming Alaska oil drilling
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) aims to raise up to the equivalent of £2.62 million (A$5.03 million) to help fund drill plans in Alaska. The AIM and ASX-listed explorer pricing the issue at A$0.029 a share, or about 1.508p.
80 Mile shares up as it eyes more liquidity in London
80 Mile PLC (AIM:80M, OTCQB:BLLYF) shares jumped on Wednesday as it revealed it is moving its shares from the London Stock Exchange's SETSqx platform to SETS from today, a step the company said should widen investor access and improve liquidity. The AIM-listed explorer and developer said the move to SETS, the exchange's electronic order book for equities, is intended to broaden its shareholder base and make the stock more accessible to investors, including those trading internationally, through traditional order-book dealing.
Sovereign Metals upgrades Kasiya resource estimate by 32% ahead of feasibility study
The Malawi-based miner's flagship deposit remains the world's largest natural rutile reserve Sovereign Metals Ltd (ASX:SVM, OTCQX:SVMLF, AIM:SVML, FRA:SVM), the AIM-listed critical minerals company, has significantly upgraded the resource estimate for its Kasiya project in Malawi, sending shares up 9% to 44p. The updated mineral resource estimate (MRE) shows measured and indicated contained rutile rising 32% to 16.1 million tonnes, covering 1.65 billion tonnes of ore graded at 0.98% rutile.
Tower Resources raises £1.5m as key project advance
Tower Resources PLC (AIM:TRP, FRA:ULF1) has raised £1.5 million of new funding to repay a bridge loan as it approaches long-awaited farm-out approvals in Cameroon and Namibia, which could clear the way for the group's next operational steps in both markets. The AIM-listed Africa-focused oil and gas company said Cameroon's state oil company SNH has told it it will recommend both a one-year extension of the Thali licence to March 2027 and approval for Prime Global Energies to acquire a 42.5% stake in the licence, though Tower is still waiting for written confirmation.
Helix Exploration takes tangible step towards production as US helium supply squeeze continues
HeLIX Exploration PLC (AIM:HEX, OTCQB:HHEXF) has secured its first helium transport trailer, a practical step toward commercial production at its Rudyard project in Montana as disruption in Qatar squeezes global supply. The AIM-listed group told investors it has signed a lease for a ten-cylinder jumbo tube trailer with capacity to carry 156,300 standard cubic feet of compressed helium at a working pressure of 2,669 PSI.
Allergy Therapeutics peanut vaccine shows strong immune response in early trial
AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed allergy immunotherapy company, has reported positive biomarker results from its PROTECT Phase I/IIa trial of VLP Peanut, a virus-like particle (VLP) vaccine designed to treat peanut allergy. The data showed a strong and consistent immune response across all trial participants, with higher doses associated with greater reductions in basophil sensitivity, a measure of how reactive immune cells are to allergens.
Buccaneer Energy seals funding as it looks to boost oil production
Buccaneer Energy Plc (AIM:BUCE, FRA:LMU1) confirmed to investors it has closed a £350,000 fundraise to finance an adjacent producing-well acquisition in East Texas and push ahead with an Organic Oil Recovery (OOR) programme that it says has already doubled output in a pilot area. The AIM-quoted group issued new shares priced at 0.01p, with participation from institutional investor Premier Miton, alongside directors, management and existing shareholders.
Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes
The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed biotechnology company specialising in allergy treatments, said it would present positive clinical and safety data from across its research portfolio at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Philadelphia. The company's flagship grass pollen treatment, Grass MATA MPL, delivered a statistically significant 22.5% improvement in a combined symptom and medication score compared with placebo across two phase III clinical trials.
TomCo Energy agrees new Valkor deal and raises some working capital, shares drop
TomCo Energy PLC (AIM:TOM, OTC:TMCGF) shares dropped 35% on Monday, falling to 0.035p, impacted by expected new equity dilution, after it announced a renewed partnership with Valkor LLC that leaves the pair jointly controlling Greenfield Energy on a 50:50 basis, as the AIM-listed group looks to progress oil-sands opportunities in Utah's Uinta Basin. The reset comes with balance-sheet engineering.
Rome Resources unearths "exciting new areas" for tin and copper at Mont Agoma
Rome Resources Plc (AIM:RMR, FRA:33R) has sharpened drill targeting at its Mont Agoma prospect in the Democratic Republic of Congo after a new geological interpretation outlined fresh, high-priority zones for both tin and copper beyond the current footprint. The AIM-listed explorer said specialist consultancy Chemostrat reworked its geological and assay database and identified a marker horizon above “Zone 3” that better predicts where mineralisation sits, splitting the sequence into five zones.
Seeing Machines flags second-half profit as EU car safety deadline nears
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z), the AIM-listed computer vision technology company, said it expected automotive production volumes to “increase materially” in the coming quarters as the EU's General Safety Regulation deadline approaches. In the update, it also forecast positive adjusted earnings before interest, tax, depreciation and amortisation in the third quarter and the second half of its financial year.
Cora Gold shares fall 12% after it unveils fundraiser for Mali project
Shares in West African explorer Cora Gold Ltd (AIM:CORA, FRA:C0J) dropped sharply after the company secured up to £15.7 million in new funding to advance its flagship mine in Mali towards production. Cora, which trades on London's AIM market, announced it had raised a minimum of £12.9 million and up to £13.7 million through a subscription led by Singapore-based investor Eagle Eye Asset Holdings.
